Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

October 08, 2015 7:08 PM ET


Company Overview of Apellis Pharmaceuticals, Inc.

Executive Profile

Michael Yeadon Ph.D.

Member of Scientific Advisory Board, Apellis Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 2 different industries.

See Board Relationships


Dr. Michael Yeadon, PhD, served as Consultant Acting Chief Scientific Officer at Apellis Pharmaceuticals, Inc. Dr. Yeadon served as the Vice President and Chief Scientific Officer of the Allergy and Respiratory Unit of Pfizer. At Pfizer, Dr. Yeadon led the creation of one of the industry's leading allergy and respiratory portfolios, crafting a compelling strategy for the Allergy and Respiratory business, leveraging linkages between indications and exploiting inflammation ...

Corporate Headquarters

6400 Westwind Way
Crestwood, Kentucky 40014

United States

Phone: 502-241-4114
Fax: --

Board Members Memberships

There is no Board Members Memberships data available.


PhD 1988
University of Surrey
University of Surrey

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Apellis Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at